Literature DB >> 8216314

Endothelin-3 mediated proliferation in wounded human umbilical vein endothelial cells.

A D Wren1, C R Hiley, T P Fan.   

Abstract

An in vitro model of endothelial cell injury was used to investigate the role of endothelins and related peptides in endothelial repair. Endothelin-3 (10-100 nM) enhanced wound repair over an 18 h period by promoting proliferation, an effect not inhibited by the specific ETA receptor antagonist BQ-123 (100 nM) or the mixed ETA/ETB antagonist PD142893 (10 microM). Like endothelin-3, the ETB selective agonists [Ala1,3,11,15]endothelin-1 and sarafotoxin S6c were able to enhance wound repair over the same dose range. Neither endothelin-1 nor endothelin-2, however, had any effect on endothelial cell wound healing. Inhibition of cyclo-oxygenase or neutralisation of basic fibroblast growth factor did not inhibit this endothelin-3-mediated event. These results suggest that endothelin-3 might have a direct role in endothelial cell proliferation as a response to injury which is not mediated by either of the currently defined ETA and ETB receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216314     DOI: 10.1006/bbrc.1993.2258

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.

Authors:  D Salani; G Taraboletti; L Rosanò; V Di Castro; P Borsotti; R Giavazzi; A Bagnato
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

2.  Role of endothelin-1 in neovascularization of ovarian carcinoma.

Authors:  D Salani; V Di Castro; M R Nicotra; L Rosanò; R Tecce; A Venuti; P G Natali; A Bagnato
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

3.  Endothelin-3 and PRL levels in the maternal and fetal circulation at delivery.

Authors:  K Dafopoulos; A Boli; A Kallitsaris; A Malamitsi-Puchner; G Kollios; I E Messinis
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

4.  Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model.

Authors:  D E Hu; C R Hiley; T P Fan
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 5.  Endothelin-1 as a target for therapeutic intervention in prostate cancer.

Authors:  E Scott Kopetz; Joel B Nelson; Michael A Carducci
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.